Zhejiang Starry Pharmaceutical Company Description

Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients in China and internationally.

It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments. The company offers preparation products comprising iohexol, iopamidol, iodixanol, iodine-methyl, iodophorol, ioflufenicol, iopromide gadoxime meglumine, gadolinate dimeglumine, gadolinium, and iohexol injections; contrast agent APIs and intermediates consisting of iohexol, iopamidol, iodixanol, iodimeperidine, iopromide, iodophorol, iodophorol hydrolysate, iohexol hydrolysate, gadobacterium meglumine iodide, and triiodoisophthaloyl chloride esters; levofloxacin hydrochloride, levofloxacin, levofluorocycloester, and levofluorocarboxylic acid; and CMO and CDMO series, including loxoprofen sodium, loxoprofen acid, trimethyliodosilane, 2-iodo-5-methylbenzoic acid, methyl o-iodobenzoate, and iodobenzene.

It also engages in technology promotion and application; investment; physical education; and wholesale activities.

Zhejiang Starry Pharmaceutical Co.,Ltd. was incorporated in 1997 and is headquartered in Taizhou, China.

Zhejiang Starry Pharmaceutical Co.,Ltd.

Country	China
Founded	1997
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,905
CEO	Weiyi Shen

Contact Details

Address: Modern Industrial Cluster Area Taizhou, 317306 China
Phone	86 576 8771 8628
Website	starrypharm.com

Stock Details

Ticker Symbol	603520
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000026N8
SIC Code	2833

Key Executives

Name	Position
Weiyi Shen	Vice Chairman and GM
Junfeng Guo	Secretary and Chief Financial Officer
Chaoyang Yao	Deputy General Manager
Chun Ye	Deputy General Manager
Wentao Huang	Accounting Supervisor